ArticleIDCases2019
Hypermucoviscous
Article in IDCases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 61 citations in OpenAlex.
- Phenotypic and genotypic analysis of hypermucoviscousIranian journal of microbiology · 2025Article
- Determination of the prevalence of hypervirulent Klebsiella pneumoniae strains in Northeast Iran, Mashhad.Scientific reports · 2025Article
- Investigating the phenotypic alterations associated with hypermucoviscous hypervirulent Klebsiella pneumoniae during phage resistance development.BMC microbiology · 2025Article
- Article
- Genotypic characterization of hypervirulent Klebsiella pneumoniae (hvKp) in a tertiary care Indian hospital.International microbiology : the official journal of the Spanish Society for Microbiology · 2024Article
- Klebsiella pneumoniae O-polysaccharide biosynthesis highlights the diverse organization of catalytic modules in ABC transporter-dependent glycan assembly.The Journal of biological chemistry · 2024Article
- Review
- Polyproline peptide targetsCell reports. Physical science · 2024Article
- General Overview ofBiology · 2024Review
- Genomic surveillance indicates clonal replacement of hypervirulentFrontiers in microbiology · 2024Article
- Clinical and Microbiological Risk Factors for 30-Day Mortality of Bloodstream Infections Caused by OXA-48-ProducingPathogens (Basel, Switzerland) · 2023Article
- Pyogenic liver abscess caused by extended-spectrum β-lactamase-producing hypervirulentThe Journal of international medical research · 2023Review
- Enhancement of capsular hypermucoviscosity in Klebsiella pneumoniae by Acanthamoeba.PLoS neglected tropical diseases · 2023Article
- Global spread and evolutionary convergence of multidrug-resistant and hypervirulentPathogens and global health · 2023Review
- Hypermucoviscous Klebsiella pneumoniae: A Hypervirulent Strain Masquerading as Metastasis.Cureus · 2023Article
- Activated Platelets Mediate Monocyte Killing of Klebsiella pneumoniae.Infection and immunity · 2023Article
- Answer to February 2023 Photo Quiz.Journal of clinical microbiology · 2023Article
- SevereWorld journal of clinical cases · 2022Article
- Anti-Biofilm and Associated Anti-Virulence Activities of Selected Phytochemical Compounds againstPlants (Basel, Switzerland) · 2022Article
- Analysis of hypervirulent Klebsiella pneumoniae and classic Klebsiella pneumoniae infections in a Chinese hospital.Journal of applied microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 1986, a new syndrome was described in Taiwan secondary to hypervirulent
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.